Blue Route

blue-route.ai ↗ ·Barcelona ·Pre-seed

Blue Route (Blue Route Technologies for Neurodevelopment) is a Barcelona-based digital health company developing AI-powered tools for early screening, diagnosis and personalised digital therapy of neurodevelopmental disorders, with a primary focus on Autism Spectrum Disorder. Its platform, La Ruta Azul, combines guided screening for families, AI analysis of behaviour from video and adaptive digital therapy. It is built to European medical device and data protection rules and sold under a hybrid B2C and B2B model, with an initial assessment at about €300 and a therapy subscription at €100 per month. The project began in 2024 when it won the AI & mHealth Challenge run by GooApps and GooVentures, and it reached more than 8,000 users during its validation phase. It has raised over €400,000 at pre-seed stage, split between private investment through the GooVentures venture studio and public funding that includes a Plan Investigo Asturias research grant.

SectorsDigital Health, Artificial Intelligence, Digital Therapeutics, Neurodevelopment Start-up MapHealthtech & Bio › Clinical software & health data

Suggest a correction

Founders

Eric Garcia
Co-founder & CTO

Global models 5

Elemy
United States · www.elemy.com ↗
Tech-led autism care platform that combined virtual diagnostic evaluations with personalised online and in-home behavioural therapy, sold to families and paid for by insurers, close to Blue Route's mix of assessment followed by ongoing therapy.
$323MComparable
Cognoa
United States · cognoa.com ↗
The closest match: an AI medical device (Canvas Dx, FDA-authorised) that analyses parent questionnaires and home videos of a child's behaviour to diagnose autism early, sold through clinicians and payers after starting as a screening app for parents.
$127MComparable
AnswersNow
United States · getanswersnow.com ↗
Virtual autism therapy platform that uses AI to personalise learning modules for each child, delivered to families as ongoing therapy, the same model as Blue Route's adaptive digital therapy subscription.
$66MComparable
EarliTec Diagnostics
United States · earlitecdx.com ↗
FDA-cleared device that measures how toddlers look at video (eye tracking) and uses it to diagnose autism early, sold to clinics; it matches Blue Route's video-based diagnostic side but offers no therapy.
$41MComparable
Frontera Health
AI-backed autism assessment and therapy service that uses digital phenotyping of recorded sessions to support diagnosis and personalise care for families, the same screen, diagnose and treat model.
$32MComparable

In the same niche 51 others

Most funded firstSee all 52 in Clinical software & health data →

Investors 1

GooVentures
Investor United States No profile

Funding rounds 1

·1 not counted
DateRoundAmountLead
Not counted (1)

Not counted in totals

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list